ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events Share: LinkedInTweet The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October 2, at which several of Signant’s clinical science and medicine leaders presented posters during the Scientific Program. The research they showcased represents the broad array of therapeutic area expertise at Signant and reflects our commitment advancing CNS clinical science. Peruse the posters below and learn more about some of the authors here. Monitoring of Scale Administration and Videography Improves Quality in a Study of a Rare Genetic Neuromuscular Disease Signant authors: Marcela Roy, Petra Reksoprodjo, Dorin Ariton, Ekaterina Ivanova, Joan Busner Download PosterClick to enlargePositive and Negative Symptom Predominance in the Screening Period in Acute Schizophrenia Trials: An Exploratory Analysis Signant authors: Alan Kott, Xingmei Wang, David Daniel Download PosterClick to enlargeImpact of Protocol Design on Between Scale Discrepancies in Early AD Clinical Trials Signant Authors: David S. Miller and Alan Kott Download PosterClick to enlargeExploring Discordant Data in Dementia Clinical Trials Signant Authors: Alan Kott, David S. Miller Download PosterClick to enlargeAssessing the Severity of Anxiety Symptoms at Study Entry into Acute Schizophrenia Clinical Trials Signant Authors: David Daniel, Xingmei Wang, Alan KottDownload PosterClick to enlargeBorderline across Borderlines: Regional Variations in Who Enters Clinical Trials Signant Authors: Juliet Brown, Sayaka Machizawa, Rachel Berman, Gary SachsDownload PosterClick to enlarge Signant Health facebook twitter google-plus linkedin Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics. Recent Posts eCOA Clinical Viewpoints Episode 1 Recap – Optimizing Pediatric Trials to Generate High-Quality Data Feb 07, 2023 Signant Health Learn more eCOA Webinar Recap: Decentralized by Design-Optimizing Trials for Remote Conduct Feb 07, 2023 Signant Health Learn more eCOA Trial Optimization as the Focus for Decentralized Methods Dec 12, 2022 Signant Health Learn more eCOA A Modular Approach to PROM Implementation – Reflections from ISPOR Europe 2022 Dec 08, 2022 Alexandra Kalpadakis-Smith Learn more eCOA Computerized Adaptive Tests: A Primer Dec 01, 2022 Bill Byrom Learn more
The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October 2, at which several of Signant’s clinical science and medicine leaders presented posters during the Scientific Program. The research they showcased represents the broad array of therapeutic area expertise at Signant and reflects our commitment advancing CNS clinical science. Peruse the posters below and learn more about some of the authors here. Monitoring of Scale Administration and Videography Improves Quality in a Study of a Rare Genetic Neuromuscular Disease Signant authors: Marcela Roy, Petra Reksoprodjo, Dorin Ariton, Ekaterina Ivanova, Joan Busner Download PosterClick to enlargePositive and Negative Symptom Predominance in the Screening Period in Acute Schizophrenia Trials: An Exploratory Analysis Signant authors: Alan Kott, Xingmei Wang, David Daniel Download PosterClick to enlargeImpact of Protocol Design on Between Scale Discrepancies in Early AD Clinical Trials Signant Authors: David S. Miller and Alan Kott Download PosterClick to enlargeExploring Discordant Data in Dementia Clinical Trials Signant Authors: Alan Kott, David S. Miller Download PosterClick to enlargeAssessing the Severity of Anxiety Symptoms at Study Entry into Acute Schizophrenia Clinical Trials Signant Authors: David Daniel, Xingmei Wang, Alan KottDownload PosterClick to enlargeBorderline across Borderlines: Regional Variations in Who Enters Clinical Trials Signant Authors: Juliet Brown, Sayaka Machizawa, Rachel Berman, Gary SachsDownload PosterClick to enlarge Signant Health facebook twitter google-plus linkedin Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics.